About

Let me introduce myself.

Chloe has distinguished herself as a strong and strategic storyteller. Coupled with her passion for everything science, she has contributed her expertise across a variety of diseases states including rheumatology, oncology, inflammation, and dermatology. Over time though, she has positioned herself as a focused oncology copywriter. 

Chloe’s first big experience was working on the global launch of the Amgen Biosimilars, Kanjinti and Amgevita. She was instrumental in strategy, concepting, asset creation, and regulatory approvals. Then, in 2018, a love for oncology brought her to CDMNY.

Since then, she has shared her sharp strategic thinking, as well as her bright creativity with all parts of the NINLARO business. She has nimbly provided unbranded and branded materials across the US and Global business for all audiences (patient, nurse, NP, PA, HCP). She was also instrumental in helping lead the launch of the PI3k-δ/γ inhibitor, COPIKTRA.

Chloe has a B.S. in Biochemistry from McGill University and an M.S. in Journalism from Columbia University. She loves to play volleyball, is an avid biker, runner and traveler. Her favorite cities include Vienna, Paris, and Istanbul.